Neurovascular Devices Market Analysis By Device Type, By Therapeutic Applications And Segment Forecasts, 2013 - 2024

  • ID: 3989876
  • Report
  • 97 pages
  • Grand View Research
1 of 3
The global neurovascular device market was valued at USD 1.62 billion in the year 2015 and is expected to reach a value of USD 2.92 billion by 2024, growing at a CAGR of 6.5%.

Key factors driving the market growth include increase in patients suffering from cerebral vascular disorders mandating assistance of neurovascular devices such as cerebral embolization and aneurysm coils, implementation of advanced technological platforms in this field, and the favorable reimbursement policies across established markets such as the U.S., Canada, U.K., Germany, and Japan.

The market is segmented on the basis of device type and respective therapeutic applications. The embolization coils are widely employed in the treatments of strokes and cerebral aneurysms. They are responsible for majority of market share in the device type segment. According to World Health Organization (WHO), strokes are the leading cause of disability and third cause of death across the world. Stroke therapeutic application segment accounts for the largest market as compared to others. In addition, according to the American Heart Association, nearly 5% of the population is currently suffering from the cerebral aneurysms. Aneurysms can cause moderate to severe brain damage depending upon the condition. Therefore, their treatment is contributing to the increased demand of these platforms.

The embolization and aneurysms coiling devices are minimally invasive and are employed in effectively treating the aneurysms. Several diseases can be treated with the help of a single coil however; the unusual cerebral aneurysms require several expensive coils. Due to the efficacy, the volume for these procedures has increased over the years. This trend will continue over the forecast period, thereby rendering the leading position for this segment in terms of revenue share. The stenting systems possess the potential to address complex natured aneurysms, which were untreatable in the past. Hence, the cerebral angioplasty and stenting systems will exhibit an impressive growth pattern during the forecast period.

Moreover, Stryker Corporation is a key leader in the neurovascular device market, owing to the strategic acquisition of complete neurovascular portfolio of Boston Scientific Corporation in the year 2010. The other notable players in this industry include Abbott Laboratories, W.L. Gore & Associates, Inc., Micorport Scientific Corporation, and Terumo Corporation.

Further Key Findings from the Study Suggest:

Rising incidence of cerebral vascular disorders such as strokes (both ischemic and hemorrhagic), arterial stenosis, and brain aneurysms are primarily responsible for the high demand for neurovascular diseases.

On the basis of types, the market is segmented into embolization and aneurysms coils, stenting systems, neurothrombectomy and support devices. Among these, embolic coils are widely used owing to the safety and efficacy, followed by the stenting systems.

According to the therapeutic application of the device type, stroke accounts for the largest market share, reason being the leading cause of disability and third cause of deaths worldwide.

In addition, the rising geriatric population and increased life expectancy are causing an increase in the target patient population.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Methodology & Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
2 Executive Summary
3 Market Summary
4 Market Variables, Trends& Scope
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.2 Market Restraint Analysis
4.2 Penetration & growth prospect mapping
4.3 Neurovascular Devices Market - SWOT Analysis, By Factor (political & legal, economic and technological)
4.4 Industry Analysis - Porter’s
5 Market Categorization 1: Device Type Estimates & Trend Analysis
5.1 Neurovascular Devices market: Device Type movement analysis
5.2 Cerebral Embolization and Aneurysm Coiling Devices
5.2.1 Cerebral Embolization and Aneurysm Coiling Devices market, 2013 - 2024 (USD Million)
5.2.1.1 Embolic Coils market, 2013 - 2024 (USD Million)
5.2.1.2 Flow Diversion Devices market, 2013 - 2024 (USD Million)
5.2.1.3 Liquid Embolic Agents market, 2013 - 2024 (USD Million)
5.3 Cerebral Angioplasty and Stenting Systems
5.3.1 Cerebral Angioplasty and Stenting Systems market, 2013 - 2024 (USD Million)
5.3.1.1 Carotid Artery Stents market, 2013 - 2024 (USD Million)
5.3.1.2 Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices) market, 2013 - 2024 (USD Million)
5.4 Neurothrombectomy Devices
5.4.1 Neurothrombectomy Devices market, 2013 - 2024 (USD Million)
5.4.1.1 Clot retrieval Devices market, 2013 - 2024 (USD Million)
5.4.1.2 Suction Devices market, 2013 - 2024 (USD Million)
5.4.1.3 Vascular Snares market, 2013 - 2024 (USD Million)
5.5 Support Devices
5.5.1 Support Devices market, 2013 - 2024 (USD Million)
5.5.1.1 Micro catheters market, 2013 - 2024 (USD Million)
5.5.1.2 Micro guidewires market, 2013 - 2024 (USD Million)
6 Market Categorization 2: Therapeutic Applications Estimates & Trend Analysis
6.1 Neurovascular Devices market: Therapeutic Applications movement analysis
6.2 Stroke
6.2.1 Stroke market, 2013 - 2024 (USD Million)
6.3 Cerebral Artery Stenosis
6.3.1 Cerebral Artery Stenosis market, 2013 - 2024 (USD Million)
6.4 Cerebral Aneurysm
6.4.1 Cerebral Aneurysm market, 2013 - 2024 (USD Million)
6.5 Others
6.5.1 Others market, 2013 - 2024 (USD Million)
7 Market Categorization 3: Regional Estimates & Trend Analysis, by Treatment Type, and End-Use
7.1 Neurovascular Devices market share by region, 2013 & 2024
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 UK
7.3.2 Germany
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.5 Latin America
7.5.1 Mexico
7.5.2 Brazil
7.6 MEA
7.6.1 South Africa
8 Competitive Landscape
8.1 Strategy framework
8.2 Company Profiles
8.2.1 Abbott Laboratories
8.2.1.1 Company Overview
8.2.1.2 Financial Performance
8.2.1.3 Product Benchmarking
8.2.1.4 Strategic Initiatives
8.2.2 W. L. Gore & Associates, Inc.
8.2.2.1 Company Overview
8.2.2.2 Financial Performance
8.2.2.3 Product Benchmarking
8.2.2.4 Strategic Initiatives
8.2.3 Johnson and Johnson
8.2.3.1 Company Overview
8.2.3.2 Financial Performance
8.2.3.3 Product Benchmarking
8.2.3.4 Strategic Initiatives
8.2.4 Medtronic
8.2.4.1 Company Overview
8.2.4.2 Financial Performance
8.2.4.3 Product Benchmarking
8.2.4.4 Strategic Initiatives
8.2.5 Merit Medical Systems, Inc.
8.2.5.1 Company Overview
8.2.5.2 Financial Performance
8.2.5.3 Product Benchmarking
8.2.5.4 Strategic Initiatives
8.2.6 Microport Scientific Corporation
8.2.6.1 Company Overview
8.2.6.2 Financial Performance
8.2.6.3 Product Benchmarking
8.2.6.4 Strategic Initiatives
8.2.7 Penumbra, Inc.
8.2.7.1 Company Overview
8.2.7.2 Financial Performance
8.2.7.3 Product Benchmarking
8.2.7.4 Strategic Initiatives
8.2.8 Stryker Corporation
8.2.8.1 Company Overview
8.2.8.2 Financial Performance
8.2.8.3 Product Benchmarking
8.2.8.4 Strategic Initiatives
8.2.9 Terumo Corporation
8.2.9.1 Company Overview
8.2.9.2 Financial Performance
8.2.9.3 Product Benchmarking
8.2.9.4 Strategic Initiatives

List of Tables

Table 1 Country share estimation
Table 2 North America Neurovascular Device market, by Devices type, 2013 - 2024 (USD Million)
Table 3 North America Neurovascular Device market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 4 U.S. Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 5 U.S. Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 6 Canada Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 7 Canada Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 8 Europe Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 9 Europe Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 10 UK Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 11 UK Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 12 Germany Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 13 Germany Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 14 Asia Pacific Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 15 Asia Pacific Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 16 Japan Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 17 Japan Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 18 China Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 19 China Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 20 India Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 21 India Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 22 Latin America Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 23 Latin America Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 24 Mexico Neurovascular Devices market, by Devices type, 2013 - 2024 (USD Million)
Table 25 Mexico Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 26 Brazil Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 27 Brazil Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 28 MEA Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 29 MEA Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
Table 30 South Africa Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
Table 31 South Africa Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)

List of Figures

Figure 1 Market summary
Figure 2 Market trends & outlook
Figure 3 Neurovascular Devices : Market Segmentation
Figure 4 Market driver relevance analysis (Current & future impact)
Figure 5 Market restraint analysis (Current & future impact)
Figure 6 Penetration & growth prospect mapping
Figure 7 SWOT Analysis, By Factor (political & legal, economic and technological)
Figure 8 Neurovascular Devices Porter’s analysis
Figure 9 Neurovascular Devices market Devices type outlook key takeaways
Figure 10 Neurovascular Devices market: Devices type movement analysis
Figure 11 Global Cerebral Embolization and Aneurysm Coiling Devices market, 2013 - 2024 (USD Million)
Figure 12 Global Embolic Coils market, 2013 - 2024 (USD Million)
Figure 13 Global Flow Diversion Devices market, 2013 - 2024 (USD Million)
Figure 14 Global Liquid Embolic Agents market, 2013 - 2024 (USD Million)
Figure 15 Global Cerebral Angioplasty and Stenting Systems market, 2013 - 2024 (USD Million)
Figure 16 Global Carotid Artery Stents market, 2013 - 2024 (USD Million)
Figure 17 Global Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices) market, 2013 - 2024 (USD Million)
Figure 18 Global Neurothrombectomy Devices market, 2013 - 2024 (USD Million)
Figure 19 Global Clot retrieval Devices market, 2013 - 2024 (USD Million)
Figure 20 Global Suction Devices market, 2013 - 2024 (USD Million)
Figure 21 Global Vascular Snares market, 2013 - 2024 (USD Million)
Figure 22 Global Support Devices market, 2013 - 2024 (USD Million)
Figure 23 Global Micro catheters market, 2013 - 2024 (USD Million)
Figure 24 Global Micro guidewires market, 2013 - 2024 (USD Million)
Figure 25 Neurovascular Devices market Therapeutic applications outlook key takeaways
Figure 26 Neurovascular Devices market: Therapeutic applications movement analysis
Figure 27 Global Stroke market, 2013 - 2024 (USD Million)
Figure 28 Global Cerebral Artery Stenosis market, 2013 - 2024 (USD Million)
Figure 29 Global Cerebral Aneurysm market, 2013 - 2024 (USD Million)
Figure 30 Global Others market, 2013 - 2024 (USD Million)
Figure 31 Regional market place: Key takeaways
Figure 32 Regional outlook, 2015 & 2024
Figure 33 Strategy framework
Figure 34 Participant categorization
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll